No association of Catechol-O-Methyltransferase (COMT) Gene Haplotypes in Patients with Schizophrenia in a Turkish Sample

References

• Danielyan A, Nasrallah HA. Neurological disorders in schizophrenia. Psychiatric Clinics of North America 2009; 32(4): 719–57. [CrossRef]
   PubMed Web of Science ®Google Scholar
• Sawa A, Snyder SH. Schizophrenia: Diverse Approaches to a Complex Disease. Science 2002; 296(5568): 692–5. [CrossRef]
   PubMed Web of Science ®Google Scholar
• Schultz SH, North SW, Shields CG. Schizophrenia: a review. Am Fam Physician 2007; 75(12): 1821–9.
   PubMed Web of Science ®Google Scholar
• Lindsay EA, Goldberg R, Jurecic V, Morrow B, Carlson C, Kucherlapati RS, et al. Velo-cardio-facial syndrome: fr equency and extent of 22q11 deletions. Am J Med Genet 1995; 57(3): 514–22. [CrossRef]
   Web of Science ®Google Scholar
• Murphy KC, Jones LA, Owen MJ. High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch Gen Psychiatry 1999; 56(10): 940–5. [CrossRef]
   PubMed Web of Science ®Google Scholar
• Lachman HM, Papolos DF, Saito T, Yu YM, Szumlanski CL, Weinshilboum RM. Human catechol-O-methyltransferase pharmacogenetics: description ofa functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 1996; 6(3): 243–50. [CrossRef]
   PubMedGoogle Scholar
• Altinyazar V, Gunderici A. Personality traits of schizophrenic patients in remission and their first-degree relatives: a dopaminergic and glutamatergic gene polymorphism study. Klinik Psikofarmakoloji Bulteni-Bulletin of Clinical Psychopharmacology 2013; 23(2): 138–48. [CrossRef]
   Web of Science ®Google Scholar
• Fan JB, Zhang CS, Gu NF, Li XW, Sun WW, Wang HY, et al. Catechol-O-methyltransferase gene Val/Met functional polymorphism and risk of schizophrenia: a large-scale association study plus meta-analysis. Biol Psychiatry 2005; 57(2): 139–44. [CrossRef]
   PubMed Web of Science ®Google Scholar
• Munafo MR, Bowes L, Clark TG, Flint J. Lack of association of the COMT (Val158/108 Met) gene and schizophrenia: a meta-analysis of case-control studies. Mol Psychiatry 2005; 10(8): 765–70. [CrossRef]
   Web of Science ®Google Scholar
• Costas J, Sanjuán J, Ramos-Ríos R, Paz E, Agra S, Ivorra JL, et al. Heterozygosity at catechol-O-methyltransferase Val158Met and schizophrenia: new data and meta-analysis. J Psychiatr Res 2011; 45(1): 7–14. [CrossRef]
   Web of Science ®Google Scholar
• Chen J, Lipska BK, Halim N, Ma QD, Matsumoto M, Melhem S, et al. Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. Am J Hum Genet 2004; 75(5): 807–21. [CrossRef]
   PubMed Web of Science ®Google Scholar
• Bray NJ, Buckland PR, Williams NM, Williams HJ, Norton N, Owen MJ, et al. A haplotype implicated in schizophrenia susceptibility is associated with reduced COMT expression in human brain. Am J Hum Genet 2003; 73(1): 152–61. [CrossRef]
   PubMed Web of Science ®Google Scholar
• Honea R, Verchinski BA, Pezawas L, Kolachana BS, Callicott JH, Mattay VS, et al. Impact of interacting functional variants in COMT on regional gray matter volume in human brain. Neuroimage 2009; 45(1): 44–51. [CrossRef]
   Web of Science ®Google Scholar
• Shifman S, Bronstein M, Sternfeld M, Pisanté-Shalom A, Lev-Lehman E, Weizman A, et al. A highly significant association between a COMT haplotype and schizophrenia. Am J Hum Genet 2002; 71(6): 1296–302. [CrossRef]
   PubMed Web of Science ®Google Scholar
• Meyer-Lindenberg A, Nichols T, Callicott JH, Ding J, Kolachana B, Buckholtz J, et al. Impact of complex genetic variation in COMT on human brain function. Mol Psychiatry 2006; 11(9): 867–77. [CrossRef]
   PubMed Web of Science ®Google Scholar
• Varma GS, Karadag F, Erdal ME, Ay OI, Levent N, Tekkanat C, et al. Effects of catechol-O-methyltransferase enzyme Val158Met polymorphism on cognitive functions in schizophrenic patients. Klinik Psikofarmakoloji Bulteni-Bulletin of Clinical Psychopharmacology 2011; 21(1): 24–32. [CrossRef] (Turkish)
   Google Scholar
• Palmatier MA, Pakstis AJ, Speed W, Paschou P, Goldman D, Odunsi A, et al. COMT haplotypes suggest P2 promoter region relevance for schizophrenia. Mol Psychiatry 2004; 9(9): 859–70. [CrossRef]
   Web of Science ®Google Scholar
• Lee SG, Joo Y, Kim B, Chung S, Kim HL, Lee I, et al. Association of Ala72Ser polymorphism with COMT enzyme activity and the risk of schizophrenia in Koreans. Hum Genet 2005; 116(4): 319–28. [CrossRef]
   PubMed Web of Science ®Google Scholar
• Funke B, Malhotra AK, Finn CT, Plocik AM, Lake SL, Lencz T, et al. COMT genetic variation confers risk for psychotic and affective disorders: a case control study. Behav Brain Funct 2005; 1: 19. [CrossRef]
   PubMed Web of Science ®Google Scholar
• Chien YL, Liu CM, Fann CS, Liu YL, Hwu HG. Association of the 3′ region of COMT with schizophrenia in Taiwan. J Formos Med Assoc 2009; 108(4): 301–9. [CrossRef]
   Web of Science ®Google Scholar
• Okochi T, Ikeda M, Kishi T, Kitajima T, Kinoshita Y, Kawashima K, et al. Meta-analysis of association between genetic variants in COMT and schizophrenia: an update. Schizophr Res 2009; 110(1–3): 140–8. [CrossRef]
   PubMed Web of Science ®Google Scholar
• Mukherjee N, Kidd KK, Pakstis AJ, Speed WC, Li H, Tarnok Z, et al. The complex global pattern of genetic variation and linkage disequilibrium at catechol-O-methyltransferase. Mol Psychiatry 2010; 15(2): 216–25. [CrossRef]
   Web of Science ®Google Scholar
• Nieratschker V, Frank J, Mühleisen TW, Strohmaier J, Wendland JR, Schumacher J, et al. The catechol-O-methyl transferase (COMT) gene and its potential association with schizophrenia: findings from a large German case-control and family-based sample. Schizophr Res 2010; 122(1–3): 24–30. [CrossRef]
   Web of Science ®Google Scholar
• Hoda F, Nicholl D, Bennett P, Arranz M, Aitchison KJ, al-Chalabi A, et al. No association between Parkinson's disease and low-activity alleles of catechol O-methyltransferase. Biochem Biophys Res Commun 1996; 228(3): 780–4. [CrossRef]
   Web of Science ®Google Scholar
• Stein MB, Fallin MD, Schork NJ, Gelernter J. COMT Polymorphisms and Anxiety-Related Personality Traits. Neuropsychopharmacology 2005; 30(11): 2092–102. [CrossRef]
   PubMed Web of Science ®Google Scholar
• DeMille MM, Kidd JR, Ruggeri V, Palmatier MA, Goldman D, Odunsi A, et al. Population variation in linkage disequilibrium across the COMT gene considering promoter region and coding region variation. Hum Genet 2002; 111(6): 521–37. [CrossRef]
   PubMed Web of Science ®Google Scholar
• Straub RE, MacLean CJ, Ma Y, Webb BT, Myakishev MV, Harris-Kerr C, et al. Genome-wide scans of three independent sets of 90 Irish multiplex schizophrenia families and follow-up of selected regions in all families provides evidence for multiple susceptibility genes. Mol Psychiatry 2002; 7(6): 542–59. [CrossRef]
   Web of Science ®Google Scholar
• Matsumoto Y, Suzuki A, Ishii G, Oshino S, Otani K, Goto K. The-181 A/C polymorphism in the excitatory amino acid transporter-2 gene promoter affects the personality trait of reward dependence in healthy subjects. Neurosci Lett 2007; 427(2): 99–102. [CrossRef]
   Web of Science ®Google Scholar
• Herken H, Erdal ME. Catechol-O-methyltransferase gene polymorphism in schizophrenia: evidence for association between symptomatology and prognosis. Psychiatr Genet 2001; 11(2): 105–9. [CrossRef]
   Web of Science ®Google Scholar
• Sazci A, Ergul E, Kucukali I, Kilic G, Kaya G, Kara I. Catechol-O-methyltransferase gene Val108/158Met polymorphism, and susceptibility to schizophrenia: association is more significant in women. Brain Res Mol Brain Res 2004; 132(1): 51–6. [CrossRef]
   Google Scholar
• Voisey J, Swagell CD, Hughes IP, Lawford BR, Young RM, Morris CP. HapMap tag-SNP analysis confirms a role for COMT in schizophrenia risk and reveals a novel association. Eur Psychiatry 2012; 27(5): 372–6. [CrossRef]
   Web of Science ®Google Scholar
• Nunokawa A, Watanabe Y, Muratake T, Kaneko N, Koizumi M, Someya T. No associations exist between five functional polymorphisms in the catechol-O-methyltransferase gene and schizophrenia in a Japanese population. Neurosci Res 2007; 58(3): 291–6. [CrossRef]
   Web of Science ®Google Scholar
• Cordeiro Q, Silva RT, Vallada H. Association study between the rs165599 catechol-O-methyltransferase genetic polymorphism and schizophrenia in a Brazilian sample. Arq Neuropsiquiatr 2012; 70(12): 913–6. [CrossRef]
   Web of Science ®Google Scholar
• Chen CY, Lu RB, Yeh YW, Shih MC, Huang SY. Association study of catechol-O-methyltransferase gene polymorphisms with schizophrenia and psychopathological symptoms in Han Chinese. Genes Brain Behav 2011; 10(3): 316–24. [CrossRef]
   Web of Science ®Google Scholar
• Kang HJ, Choe BM, Kim SH, Son SR, Lee KM, Kim BG, et al. No Association Between Functional Polymorphisms in COMT and MTHFR and Schizophrenia Risk in Korean Population. Epidemiol Health 2010; 32:e2010011. [CrossRef]
   Google Scholar
• Kong FZ, Peng ZZ, Jıang TY, Hong XH. An association study of COMT gene polymorphisms with schizophrenia. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2011; 28(2): 208–11. [CrossRef]
   Google Scholar
• Li WJ, Kou CG, Yu Y, Sun S, Zhang X, Kosten TR, et al. Association of catechol-O-methyltransferase gene polymorphisms with schizophrenia and negative symptoms in a Chinese population. Am J Med Genet B Neuropsychiatr Genet 2012; 159B(4): 370–5. [CrossRef]
   Web of Science ®Google Scholar
• Zhang F, Liu C, Chen Y, Wang L, Lu T, Yan H, et al. No association of catechol-O-methyltransferase polymorphisms with schizophrenia in the Han Chinese population. Genet Test Mol Biomarkers 2012; 16(9): 1138–41. [CrossRef]
   Web of Science ®Google Scholar